Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto 606-8501, Japan.
Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Cells. 2019 May 10;8(5):440. doi: 10.3390/cells8050440.
Chorioallantoic membrane assay (CAM assay) using fertilized chicken eggs has been used for the study of tumor formation, angiogenesis and metastasis. Recently, there is growing realization that this system provides a valuable assay for a patient-derived tumor model. Several reports establish that tumor samples from cancer patients can be used to reproduce tumor in the chicken egg. High transplantation efficiency has been achieved. In this review, we discuss examples of transplanting patient tumors. We then discuss critical issues that need to be addressed to pursue this line of experiments. The patient-derived chicken egg model (PDcE model) has an advantage over other models in its rapid tumor formation. This raises the possibility that the PDcE model is valuable for identifying optimum drug for each individual patient.
鸡胚尿囊膜检测(CAM 检测)已被广泛应用于肿瘤形成、血管生成和转移等方面的研究。近来,人们逐渐认识到,该系统还为患者源性肿瘤模型提供了一种有价值的检测方法。有多项研究报道表明,来自癌症患者的肿瘤样本可用于在鸡胚中重现肿瘤。目前已实现了较高的移植效率。在本文中,我们将讨论将患者肿瘤进行移植的范例,并探讨开展此类实验需要解决的关键问题。与其他模型相比,患者源性鸡胚模型(PDcE 模型)具有快速形成肿瘤的优势,这使得该模型在为每位患者寻找最佳药物方面具有潜在价值。